iShares MSCI Germany ETF EWG Rides Broad 2025 Global Equity Surge to AllTime High Should I buy Swarmer SWMR stock NOMADAR NOMA CEO prioritizes emerging market penetration and core product upgrades to fuel longterm gains TSM Taiwan posts 45 percent EPS beat and 316 percent year over year revenue growth stock dips 09 percent Department of Energy Highlights Progress in Electric Vehicle Battery and Charging Infrastructure SKYX Platforms SKYX Q1 2026 Results Fall Short EPS 007 Revenue NA South Koreas Kospi Tumbles 6 as AIFueled Rally Reverses Sharply Bitcoin Slips to TwoWeek Low of 76711 as USIran Tensions Rattle Crypto Markets US Stock Futures and Bond Yields Dip on Reports of Putins Updated Nuclear Doctrine Kevin Warsh Faces Potential Internal Conflict at Fed Over Rate Cut Stance Amid Inflation and Yield Surge Strategic Petroleum Reserve Falls to 40Year Low Why It May Not Signal Crisis US Productivity Growth Slows in Q4 as Unit Labor Costs Accelerate MarketWatch Report Europe Faces Connectivity Risks as US Satellite and AI Dominance Grows Telecom CEO Warns Q2 Holdings Combines Banking Growth with Practical AI Tools Amid Turnaround Potential MDRR Q2 2021 Earnings EPS Surprises to the Upside Despite Revenue Absence MGM Q1 2026 Earnings EPS Misses Estimates Amidst Operational Pressures QT Imaging Q1 2026 Earnings Wide EPS Miss and No Revenue Reported Weigh on Investor Sentiment COTY Q1 2026 Earnings EPS Misses Estimates by Wide Margin Revenue Data Unavailable ORLY Q1 2026 Earnings EPS Beats Estimates amid Solid Execution ASLE Earnings Overview 20260527 Assembly Biosciences ASMB Slides Over 4 as Biotech Sector Faces Pressure FG Imperii Warrants FGIIW Hold Steady at 025 Key Levels in Focus K Wave Media Ltd KWM Edges Higher Amid Tight Trading Range TMobile US TMUS Holds Steady Near Resistance as Trading Volume Remains Moderate NL Industries Inc NL Rises 144 as Stock Tests Key Resistance at 740 Federal Realty Investment Trust Outpaces SP 500 in 2026 Amid Steady REIT Performance OLMA Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Progress Continues Cato Corporation CATO Slips Nearly 5 as Shares Slide Toward Key Support